Volume : 09, Issue : 12, December – 2022
Title:
69.FORMULATION AND EVALUATION OF TINIDAZOLE FLOATING TABLETS
Authors :
H. Padmalatha
Abstract :
The objective of this study was to developed gastric floating drug delivery system containing Tinidazole and having a bulk density lower than that of gastric fluid and remaining buoyant on the stomach contents. In the Preformulation FTIR study was carried out for pure drug (Tinidazole), Tinidazole and excipients. It has not shown any interaction. Hence drugs were found to be compatible with excipients. The formulations were prepared by direct compression method. The angle of repose values for formulations ranges from 26.04±0.03 to 29.01±0.07. Bulk and tapped densities were used for the measurement of compressibility index. The bulk and tapped values for formulations range from 0.260±0.01 to 0.347±0.04 and 0.320±0.03 to 0.391±0.07 respectively. The carr’s index and hausner’s ratio values for formulations range from 13.12±0.03 to 16.52±0.01 and 1.08 ±0.05 to 1.19±0.06 respectively. Thus, all formulations exhibited good flow characteristics. From the study, concluded that F4 was the optimized formulation which has shown better buoyancy time 45sec and drug release 99.88% in 24hrs. However, further invivo studies can be carried out to support the results.
Key words: Formulation, Optimization, Tinidazole, Floating tablets
Cite This Article:
Please cite this article in press H. Padmalatha , Formulation And Evaluation Of Tinidazole Floating Tablets., Indo Am. J. P. Sci, 2022; 09(12).
Number of Downloads : 10
References:
2. Rocca JG, Omidian H, Shah K. Progress in gastroretentive drug delivery systems. Business briefing. Pharma Tech. 2003;5:152–6. [Google Scholar]
3. Mathur P, Saroha K, Syan N, Verma S, Kumar V. Floating drug delivery systems: An innovative acceptable approach in gastroretentive drug delivery. Arch Apll Sci Res. 2010;2:257–70. [Google Scholar]
4. Shah SH, Patel JK, Patel NV. Stomach specific floating drug delivery system: A review. Int J Pharm Tech Res. 2009;1:623–33. [Google Scholar]
5. . Streubel A, Siepmann J and Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv. 2006;3(2):217-233.
6. Nayak AK, Maji R and Das B. Gastroretentive drug delivery systems: a review. Asian J Pharm Clin Res. 2010;3(1):2-10.
7. Gopalakrishnan S and Chenthilnathan A. Floating drug delivery systems: a review. J Pharm Sci Technol. 2011;3(2):548-554.
8. Iannucelli V, Coppi G, Bernabei MT and Camerorni R. Air compartment multiple-unit system for prolonged gastric residence. Part-I, Formulation study. Int J Pharm. 1998;174:47-54.
9. Garg R and Gupta GD. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res. 2008;7(3):1055-1066.
10. Anupama S, Ratnaparkhi MP and Shilpa C. Floating drug delivery system: an overview. Int J Res Dev Pharm L Sci. 2014;3(5):1106-1115.
11. Neha N. An updated review on: floating drug de livery system. Int J App Pharm. 2011; 3(1): 1-7.
12. Badoni A, Ojha A, Gnanarajan G and Kothiyal P. Review on gastro retentive drug delivery system. Pharm Innov. 2012;1(8):32-42.
13. Deshpande AA, Shah NH, Rhodes CT and Malick W. Development of a novel controlled-release system for gastric retention. Pharm Res. 1997;14(6):815- 819.